IMA Q3 2023 Earnings — ImageneBio Inc Revenue & Financial Results | Market Cap Arena

IMAImageneBio Inc

$69M

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M-81.5% YoY

Gross Profit

$943,00079.6% margin

Operating Income

-$20M-1645.8% margin

Net Income

-$17M-1463.5% margin

EPS (Diluted)

$-0.40

QoQ Revenue Growth

-40.9%

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$20M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$215M

Total Liabilities

$28M

Stockholders' Equity

$187M

Cash & Equivalents

$121M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$6M	-81.5%
Gross Profit	$943,000	-$12M	+107.6%
Operating Income	-$20M	-$18M	-9.1%
Net Income	-$17M	-$17M	-0.0%